no research on eris yet.
dalal researches scrips that score in the top of the bse 500, and anything a user holds or watches. when a note passes its source checks, it appears here. notes that fail are never shown.
pick history
every time it was listed, and how it went.
never on a list so far.
in the knowledge base
the latest filings and news.
- Eris Life revenue rises 12.6% to ₹892 crore in Q2 FY27newspharma.economictimes.indiatimes· 27 oct 2026(opens the source in a new tab)
- Eris Lifesciences Q2 Profit Jumps 39% to Rs 187 Crnewsrediff money· 26 oct 2026(opens the source in a new tab)
- Eris Lifesciences hits an all-time high on the back of strong Q2 results; here's what Anil Singhvi says about itnewszee business· 9 nov 2023(opens the source in a new tab)
- Individual sells 2 per cent stake in Eris Lifesciences for Rs 188 crorenewsbusiness line· 7 jul 2023(opens the source in a new tab)
- Eris Lifesciences buys anti-diabetes novel drug Zomelis in India for $13 millionnewsmint· 3 dec 2019(opens the source in a new tab)
- Day 3: Eris Lifesciences IPO subscribed 3.29 timesnewsthe financial express· 20 jun 2017(opens the source in a new tab)
- Eris Lifesciences IPO Opens: Should You Invest?newsndtv· 20 jun 2017(opens the source in a new tab)
research ideas and things to consider, not personalised investment advice. every statement links to the filing or article it came from; numbers are computed by dalal from exchange data with their dates. ideas can and do lose money: the track record shows every pick, losers included. decide based on your own situation.